Stockscreener 앱 받기
2.30
1.71%
-0.04
시장 영업 전:
2.33
0.03
+1.30%
전일 마감가:
$2.34
열려 있는:
$2.42
하루 거래량:
4.78M
Relative Volume:
0.82
시가총액:
$782.60M
수익:
-
순이익/손실:
$-75.80M
주가수익비율:
-6.5714
EPS:
-0.35
순현금흐름:
$-68.07M
1주 성능:
+3.14%
1개월 성능:
+12.20%
6개월 성능:
-3.36%
1년 성능:
-20.14%
1일 변동 폭
$2.29
$2.5499
1주일 범위
$2.19
$2.5499
52주 변동 폭
$1.54
$3.455
Nuvation Bio Inc Stock (NUVB) Company Profile
명칭
Nuvation Bio Inc
전화
(415) 754-3517
주소
357 TEHAMA STREET, FLOOR 3, SAN FRANCISCO
NUVB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NUVB
Nuvation Bio Inc
|
2.30 | 799.62M | 0 | -75.80M | -68.07M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Nuvation Bio Inc Stock (NUVB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-23 | 개시 | Citizens JMP | Mkt Outperform |
| 2024-03-27 | 업그레이드 | Jefferies | Hold → Buy |
| 2024-03-26 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-01-06 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-08-02 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2022-08-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-05-04 | 개시 | H.C. Wainwright | Buy |
| 2021-10-15 | 재개 | BTIG Research | Buy |
| 2021-04-06 | 개시 | RBC Capital Mkts | Outperform |
| 2021-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2021-03-08 | 개시 | BTIG Research | Buy |
| 2021-03-08 | 개시 | Cowen | Outperform |
| 2021-03-08 | 개시 | Jefferies | Buy |
| 2021-03-08 | 개시 | Wedbush | Outperform |
모두보기
Nuvation Bio Inc 주식(NUVB)의 최신 뉴스
Nuvation Bio Inc. (NYSE:NUVB) Reported Earnings Last Week And Analysts Are Already Upgrading Their Estimates - 富途牛牛
Nuvation Bio Inc. (NUVB) Reports Q2 Loss, Beats Revenue Estimates - MSN
Nuvation Bio shares rise 1.30% after-hours after RBC raised its price target to $7. - AInvest
Nuvation Bio’s Phase 2 Study on Safusidenib: A Potential Game-Changer for IDH1 Mutant Glioma - TipRanks
RBC Raises Price Target on Nuvation Bio to $7 From $6, Keeps Outperform, Speculative Risk - MarketScreener
Nuvation Bio Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
Nuvation Bio’s Milestone with FDA Approval of IBTROZI - TipRanks
Nuvation Bio Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Nuvation Bio Reports 1,043% YoY Sales Growth, Exceeds Revenue Estimates with $4.8 Million in GAAP Revenue - AInvest
Earnings call transcript: Nuvation Bio Q2 2025 sees steady EPS, stock rises - Investing.com
Nuvation Bio Inc. SEC 10-Q Report - TradingView
Nuvation Bio earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
Earnings Flash (NUVB) Nuvation Bio Inc. Reports Q2 Revenue $4.8M - MarketScreener
New Lung Cancer Drug IBTROZI Gains FDA Approval, Reaches 70 Patients in First 7 Weeks - Stock Titan
Nuvation Bio To Present New Data on IBTROZI™ (taletrectinib) in Advanced ROS1-Positive Non-Small Cell Lung Cancer at WCLC and ESMO Annual Congresses - BioSpace
Nuvation Bio Presents New IBTROZI Data at WCLC and ESMO Congresses - AInvest
What are the latest earnings results for Nuvation Bio Inc.Consistent triple-digit returns - Jammu Links News
What makes Nuvation Bio Inc. stock price move sharplyCapitalize on market trends with confidence - Jammu Links News
Nuvation Bio Inc. Stock Analysis and ForecastDiscover undervalued stocks before they soar - Jammu Links News
Nuvation Bio (NUVB.N) Plunges 5.5%: What’s Behind the Sudden Sell-Off? - AInvest
Nuvation Bio Announces Q2 2025 Financial Results and Business Update on August 7, 2025. - AInvest
What catalysts could drive Nuvation Bio Inc. stock higher in 2025Get real-time alerts on top-performing stocks - Jammu Links News
Nuvation Bio (NUVB.N) Drops 5.5%: What’s Behind the Sudden Slide? - AInvest
How does Nuvation Bio Inc. generate profit in a changing economyFree Investment Case Studies - Jammu Links News
How does Nuvation Bio Inc. compare to its industry peersFree Trend-Following Techniques - Jammu Links News
Is Nuvation Bio Inc. a good long term investmentExceptional financial outcomes - Jammu Links News
What institutional investors are buying Nuvation Bio Inc. stockConsistent wealth multiplication - Jammu Links News
Is Nuvation Bio Inc. a growth stock or a value stockInvest in stocks with long-term growth potential - Jammu Links News
RBC Capital Maintains a Buy on Nuvation Bio (NUVB) With a $6 PT - MSN
What is the dividend policy of Nuvation Bio Inc. stockBreakout portfolio performance - Jammu Links News
What markets is GLXG expanding into Is Nuvation Bio Inc. stock a good long term investment optionUnlock powerful portfolio management tools - Jammu Links News
Quant Models Detect Momentum Reversal in Nuvation Bio Inc.AI Forecast for Trending Stocks Indicates Upside - beatles.ru
Nuvation Bio (NUVB)’s Taletrectinib Selected as Preferred Agent for Cancer Treatment - Insider Monkey
When is Nuvation Bio Inc. stock expected to show significant growthAdvanced Screener Guidance With High Returns - Jammu Links News
10 Penny Stocks That Will Skyrocket - Insider Monkey
Institutional investors may adopt severe steps after Nuvation Bio Inc.'s (NYSE:NUVB) latest 5.9% drop adds to a year losses - Yahoo Finance
What institutional flow reveals about Nuvation Bio Inc.Earnings Play Trade Plan With Alerts Shared - metal.it
Analysts Boost Healthcare Stocks: Aclaris Therapeutics and Nuvation Bio - AInvest
Nuvation Bio Inc. Outperforms Peers on Volume MetricsProfit Focused Stock Screener Results Released - metal.it
Nuvation Bio (NUVB.N) Surges 8.6% — Unpacking the Intraday Spike Without Fundamentals - AInvest
Is Nuvation Bio Inc. stock a growth or value playDaily Stock Market Swing Alerts Highlight Key Movers - metal.it
How volatile is Nuvation Bio Inc. stock compared to the marketAchieve breakthrough performance with smart picks - Jammu Links News
Nuvation Bio Inc (NUVB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):